Fabrice Egros, Director at Syndax Pharmaceuticals Inc (SNDX), sold 31,270 shares at $15.75 ($493K) on 2021-08-18, disclosed to the SEC on 2021-08-20.
Open-market sale of $493k SNDX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.75 | 15,635 | $246K | 50.0% |
| 2 | $15.75 | 15,635 | $246K | 50.0% |
| Total | $15.75 avg | 31,270 | $493K | 100% |
| Filing → |
| SNDX | SELL | 2021-03-03 | $496K | — | Filing → |